NRx Pharmaceuticals Reports Improved Financial Results for Q3 2023, Decrease in Net Loss
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently released its Q3 2023 financial results, revealing several improvements compared to the same period last year. The company also provided an …
NRx Pharmaceuticals Reports Improved Financial Results for Q3 2023, Decrease in Net Loss Read More